Cas:143112-52-1 (S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole manufacturer & supplier

Chemical Name:(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole

CAS.NO:143112-52-1

Synonyms:(S)-(+)-NBD-Apy (S)-(+)-1-(7-Nitro-4-benzofurazanyl)-3-pyrrolidinamine;(3S)-1-(7-Nitro-2,1,3-benzoxadiazol-4-yl)pyrrolidin-3-amine;(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)benzofurazan;(S)-(+)-NBD-APy;MFCD03791268;(3S)-1-(4-nitro-2,1,3-benzoxadiazol-7-yl)pyrrolidin-3-amine;(3S)-1-(7-Nitro-2,1,3-benzoxadiazol-4-yl)-3-pyrrolidinamine;3-Pyrrolidinamine, 1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3S)-;(S)-(+)-4-(3-Amino-pyrrolidino)-7-nitrobenzofurazan

Molecular Formula:C₁₀H₁₁N₅O₃

Molecular Weight:249.226

HS Code:2934999090

Physical and Chemical Properties:

Melting point:178-184ºC

Boiling point:469.7±55.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.678

PSA:114.00000

Exact Mass:249.086182

LogP:0.84

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (S)-(+)-NBD-Apy (S)-(+)-1-(7-Nitro-4-benzofurazanyl)-3-pyrrolidinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-(+)-4-(3-Amino-pyrrolidino)-7-nitrobenzofurazan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD03791268 Use and application,3-Pyrrolidinamine, 1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3S)- technical grade,usp/ep/jp grade.

Related News: Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. (S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole manufacturer Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. (S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. (S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole vendor Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. (S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole factory During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology.